Yaso Therapeutics Corporation
The goal of this clinical trial is to assess the safety and pharmacokinetics of YASO GEL in healthy adult participants. This is a first-in-human study designed to understand how the gel is absorbed and distributed in plasma and vaginal fluid, and to evaluate the methods used to measure drug levels in humans. The main questions the study aims to answer are: What is the preliminary safety and tolerability of YASO GEL at a subtherapeutic 0.7% dose? How is YASO GEL absorbed and distributed, and does sexual activity affect its pharmacokinetics? Participants will: Receive an application of YASO GEL. Provide blood and vaginal fluid samples for pharmacokinetic analysis. Participate in a sub-study evaluating the impact of sexual activity on safety and drug exposure. Additional information on product acceptability, adherence, and exploratory laboratory analyses will be collected to inform the design of future studies.
This study initiates with a first-in-human lead-in study using a subtherapeutic 0.7% dose of YASO GEL. The study aims to provide a preliminary assessment of PPCM pharmacokinetics in plasma and vaginal fluid, and to validate a bioanalytical assay to be used to measure efficacy in both the Phase 1 and sub studies. Data from this study will help ensure that pharmacokinetic sampling is adequate for subsequent clinical trials and will provide initial safety information to support a Phase 1 study. The subsequent randomized double-blind Phase 1 study will use a therapeutic 2.0% dose of YASO GEL admi…
Inclusion Criteria: * 4.1.1 Lead-in and Phase 1 Studies Individuals who meet the following criteria are eligible for inclusion in the study (see additional gender specific criteria at the end of the section): 1. Adults who are: * Women aged 18 through 45 years (inclusive) * Men aged 18 years and over at Screening 2. Cisgender individuals with no history of gender reassignment impacting hormones or genital anatomy 3. Able to communicate in English 4. Provide written informed consent before any study-related activities are carried out and must be able to understand the full nature and…
Contraceptive gel
Inactive placebo gel matching the investigational contraceptive
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.